Balakrishnan, B., An, D., Nguyen, V., DeAntonis, C., Martini, P. G., & Lai, K. (2020). Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia. Mol Ther.
Chicago-стиль цитированияBalakrishnan, Bijina, Ding An, Vi Nguyen, Christine DeAntonis, Paolo G.V Martini, and Kent Lai. "Novel MRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia." Mol Ther 2020.
MLA-цитированиеBalakrishnan, Bijina, et al. "Novel MRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia." Mol Ther 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.